Another line of reasoning, based on the hypothesis that neuronal ApoE4 fragmentation is a key event for ApoE4-induced neurotoxicity, suggests that preventing its proteolytical cleavage into fragments could be therapeutically effective in AD. This evidence concerns the gene APOE and Alzheimer disease.